---
name: UPM Pharmaceuticals
slug: upm-inc
site: cdmo
website_domain: upm-inc.com
summary: Independent, family-owned CDMO specializing in oral solids, semi-solids, and controlled-substance manufacturing with 475,000 sq ft cGMP facility in Bristol, TN; over 80 products commercialized. Headquartered in Bristol, United States.
tagline: Independent CDMO specializing in oral solids, semi-solids, and controlled substances with 475,000 sq ft Bristol, TN facility.
founded_year: 
employee_count_band: 
employee_count_label: 
parent_name: 
parent_slug: 
hq_country: US
tier2_domain_verified: false
updated_at: 2026-07-29T23:24:34.916Z
services_count: 12
modalities_count: 1
indications_count: 0
locations_count: 1
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# UPM Pharmaceuticals

Independent CDMO specializing in oral solids, semi-solids, and controlled substances with 475,000 sq ft Bristol, TN facility.

Listed on cdmo.directory.

## Summary

Independent, family-owned CDMO specializing in oral solids, semi-solids, and controlled-substance manufacturing with 475,000 sq ft cGMP facility in Bristol, TN; over 80 products commercialized. Headquartered in Bristol, United States.

## At a glance

- HQ country: US

## Services

- Formulation Development
- CMC Analytical Development
- Stability Testing & Storage
- Quality Control Testing
- Process Development
- Technology Transfer
- Oral Solid Dosage Manufacturing
- Topical & Semi-Solid Manufacturing
- Secondary Packaging & Labeling
- Serialization & Track-and-Trace
- Controlled Substance Manufacturing
- HPAPI Manufacturing (High-Potency)

## Modalities

- Small Molecule

## Locations

- Headquarters & Manufacturing Facility, Bristol, Tennessee, United States

## Long description

## Overview

UPM Pharmaceuticals is an independent, family-owned contract development and manufacturing organization (CDMO) with more than 25 years of operational history. The company combines enterprise-level capabilities with the flexibility and transparency of a family-owned business, serving pharmaceutical companies of all sizes from early-stage biotech to established Big Pharma.

## Core Services

**Drug Formulation & Development**
- Drug formulation development and analytical method development
- Stability testing and quality control
- Technology transfer and scale-up support from development to commercial production

**Manufacturing Capabilities**
- **Oral Solids:** Tablet and capsule manufacturing with annual capacity of 3.5 billion tablets and 680 million capsules
- **Semi-Solids:** 1,300 metric tons annual cGMP capacity for creams, ointments, gels, and topical products; includes emulsification, homogenization, controlled heating, viscosity management, tube filling, and jar filling
- **Sustained-Release/Extended-Release:** Controlled release technologies including delayed-release, sustained-release, and pulse-release formulations
- **Specialized Handling:** High-potent compound handling, hormone-based formulations, and DEA-licensed controlled substances (15,800 sq ft DEA-approved vault space)

**Packaging & Warehousing**
- Secondary packaging, labeling, and warehousing services
- Pharmaceutical serialization and aggregation

**Quality & Regulatory**
- cGMP-compliant manufacturing and operations
- In-process analytical testing (potency, pH, microbial limits)
- Microbiological testing lab services

## Facility

The Bristol, Tennessee campus comprises:
- 475,000 sq ft commercial pharma manufacturing facility
- 250,000 sq ft warehouse
- 15,800 sq ft DEA-approved vault space
- 7-acre pharmaceutical development campus
- Full-service analytical laboratory for solids and semi-solids testing at all scales

## Track Record

Over 80 products advanced from proof of concept to commercialization; established track record as a Big Pharma supplier with commercial pedigree in late-stage manufacturing support.

## Related companies

- [Pharmaceutics International, Inc.](/companies/pharm-int) (Formulation Development, CMC Analytical Development) — [Compare](/compare/pharm-int/upm-inc)
- [Metrics Contract Services](/companies/metricscontractservices) (Formulation Development, CMC Analytical Development) — [Compare](/compare/metricscontractservices/upm-inc)
- [Bend Bioscience](/companies/societalcdmo) (Formulation Development, CMC Analytical Development) — [Compare](/compare/societalcdmo/upm-inc)
- [CMC Pharmaceuticals, Inc.](/companies/cmcpharm) (Formulation Development, CMC Analytical Development) — [Compare](/compare/cmcpharm/upm-inc)
- [Hovione](/companies/hovione) (Formulation Development, CMC Analytical Development) — [Compare](/compare/hovione/upm-inc)
- [Quotient Sciences](/companies/quotientsciences) (Formulation Development, CMC Analytical Development) — [Compare](/compare/quotientsciences/upm-inc)
- [Delpharm](/companies/delpharm) (Formulation Development, Stability Testing & Storage) — [Compare](/compare/delpharm/upm-inc)
- [Cambrex](/companies/cambrex) (Formulation Development, CMC Analytical Development) — [Compare](/compare/cambrex/upm-inc)

_Profile last updated: 2026-07-29T23:24:34.916Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.